Article Text

Download PDFPDF
Association between genetic polymorphisms and risk of adolescent idiopathic scoliosis in case-control studies: a systematic review
  1. Elizabeth Terhune,
  2. Patricia Heyn,
  3. Christi Piper,
  4. Cambria Wethey,
  5. Anna Monley,
  6. Melissa Cuevas,
  7. Nancy Hadley Miller
  1. Department of Orthopedics, University of Colorado Denver—Anschutz Medical Campus, Aurora, Colorado, USA
  1. Correspondence to Dr Nancy Hadley Miller, University of Colorado Denver—Anschutz Medical Campus, Aurora, CO 80045, USA; nancy.hadley-miller{at}cuanschutz.edu

Abstract

Background Adolescent idiopathic scoliosis (AIS) is a structural lateral spinal curvature of ≥10° with rotation. Approximately 2%–3% of children across populations are affected with AIS, and this condition is responsible for ~$3 billion in costs within the USA. Although AIS is believed to have a strong genetic contribution, clinical translation of identified genetic variants has stalled.

Methods The databases MEDLINE (via PubMed), Embase, Google Scholar and Ovid MEDLINE were searched and limited to articles in English. Title and abstract, full-text and data extraction screening was conducted through Covidence, followed by data transfer to a custom REDCap database. Studies containing variant-level data using genome-wide methodology as well as validation studies of genome-wide methods were considered. Quality assessment was conducted using Q-Genie.

Results 33 studies were included, including 9 genome-wide association studies, 4 whole exome sequencing and 20 validation studies. Combined, these studies included data from >35,000 cases and >67,000 controls, not including validation cohorts. Additionally, results from six meta-analyses containing novel cohorts were also reported. All included study cohorts were from populations of primarily East Asian or Caucasian descent. Quality assessment found that overall study quality was high and control group selection was moderate. The highest number of reported associations were in single nucleotide polymorphisms (SNPs) in or near LBX1, LBX1-AS1, GPR126/ADGRG6 or BNC2.

Conclusion AIS risk may be influenced by specific SNPs, particularly those in/near LBX1 and GPR126. Translatability of study findings is unknown due to an underrepresentation of most ethnic groups as well as few identified genome-wide studies. Further studies may benefit from increased cohort diversity and thorough evaluation of control cohort groups.

  • genetics
  • orthopedics

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text

Footnotes

  • Contributors ET: conception and design, acquisition of data, analysis and interpretation of data, manuscript preparation. PH: conception and design, acquisition of data, analysis and interpretation of data. CP: conception and design, acquisition of data, analysis and interpretation of data. CW: acquisition of data, analysis and interpretation of data, manuscript interpretation. AM: acquisition of data, manuscript preparation. NHM: conception and design, acquisition of data, analysis and interpretation of data, manuscript preparation, guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.